Excel is everywhere—more than 750 million people open a workbook each year to balance budgets, fine-tune supply chains, and ...
Economic value accrues to those companies that allow AI models to operate at scale. This is where Australia is far more ...
Single-cell RNA-seq AI analysis has become the default way to make sense of the millions of expression measurements a single experiment can now generate. Turning raw sequencing counts into ...
The Nasdaq Composite and S&P 500 surged Monday following a holiday-shortened week, as AI-tied shares led the charge, while ...
The U.S. power grid was built for a 20th-century economy and cannot deliver what the AI boom requires. A handful of companies that secured power capacity outside the American grid are about to look ...
Nvidia is a Strong Buy, as recent stock weakness is disconnected from operational performance and driven by external ...
Nebius is rated Sell, as AI infra growth hides heavy capex, dilution, contract and margin risks amid AI compute deflation.
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-driven precision oncology company, today announced the launch of ZetaOmics, the computational-biology module of its multi-agentic AI ...
Chinese AI models are rapidly closing the gap with U.S. frontier systems. This analysis examines what their growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results